Ulu Ventures Management Company, LLCFirm match from fund name (lower confidence)
Ulu Ventures Fund IV, L.P.
Open, writing first checks
Open: first sale May 2023, per Form D (fund age approximates vintage)
- Vintage
- 2023
- Fund size
- $190.78M to $200M (Form D)
- Stages
- Seed
- Sectors
- Not stated
- Regions
- Not stated
01 · Thesis
Ulu Ventures Fund IV is the firm's seed-stage fund. The firm names it as the fund behind several portfolio companies, including Vaxess, which engineers technologies that engage the human immune system for vaccines and therapeutics.
02 · Initial check
$1.91M to $3.33M (estimated from fund size)
Estimated from Form D: $190.78M sold of a $200M target
03 · Who to approach
Named on this fund's Form D
- Clint Korver
- Miriam Rivera
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Ulu's seed-stage fund, which the firm names as the fund behind several portfolio companies. The firm says seed-stage investing is all it has ever done.
Vaxess is a Fund IV investment.
https://uluventures.com/new-investments/
06 · Sources
Last verified: Oct 25, 2026